摘要
核衣壳是乙肝病毒(HBV)的核心结构,在HBV复制感染中起到了重要作用。以核衣壳为靶标的二氢嘧啶类化合物(HAPs)是一类全新结构的高活性HBV抑制剂,有望成为一种新型的乙型肝炎治疗药物。本文就HAPs类化合物的结构特点及其抗乙肝作用机制的研究进展进行综述。
The capsid as a core structure of HBV is key to complete the viral life cycle and infection. Het- eroaryldihydropyrimidines(HAPs) targeting on viral capsid was discovered as highly potent and new struc- ture inhibitors of HBV replication in vitro and in vivo, which would be a new kind of anti-HBV drugs. Re- searching on the anti-HBV mechanism of HAPs can benefit to find more effective and safe drugs. In this re- view the progress on the structure of HAPs and the anti-HBV mechanism of HAPs were summarized.
出处
《中国药物化学杂志》
CAS
CSCD
2013年第6期493-498,共6页
Chinese Journal of Medicinal Chemistry
基金
国家自然科学基金项目(21172263)